Nedira Salzman-Frenkel.

Corporate Officer/Principal presso NEUROSENSE THERAPEUTICS LTD.

Consumer Services

Commercial Services

Health Technology

Profilo

Nedira Salzman-Frenkel is currently the Vice President-Business Development at Neurosense Therapeutics Ltd.
Previously, she served as the Chief Executive Officer at Radikal Therapeutics, Inc. from 2017 to 2021.
Ms. Salzman-Frenkel holds a graduate degree from The Hebrew University of Jerusalem, an undergraduate degree from Ben-Gurion University of the Negev, and an MBA from Recanati School of Business Administration.

Posizioni attive di Nedira Salzman-Frenkel.

Società	Posizione	Inizio
NEUROSENSE THERAPEUTICS LTD.	Corporate Officer/Principal	01/03/2022

Tutte le posizioni attive di Nedira Salzman-Frenkel.

Precedenti posizioni note di Nedira Salzman-Frenkel.

Società	Posizione	Fine
Radikal Therapeutics, Inc. Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA.	Amministratore Delegato	01/10/2021

Vedi nel dettaglio l'esperienza di Nedira Salzman-Frenkel.

Formazione di Nedira Salzman-Frenkel.

Ben-Gurion University of the Negev	Undergraduate Degree
The Hebrew University of Jerusalem	Graduate Degree
Recanati School of Business Administration	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nedira Salzman-Frenkel.

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
NEUROSENSE THERAPEUTICS LTD.	Health Technology

Aziende private	1
Radikal Therapeutics, Inc. Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA.	Commercial Services

Vedi le connessioni aziendali